Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹1,505 Cr₹1,273 Cr₹1,168 Cr₹2,009 Cr₹668 Cr

What is the latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹1,505 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹1,505 Cr
Mar2024₹1,273 Cr
Mar2023₹1,168 Cr
Mar2022₹2,009 Cr
Mar2021₹668 Cr

How is Net Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2025 ₹1,505 Cr
18.16
Mar2024 ₹1,273 Cr
9.04
Mar2023 ₹1,168 Cr
-41.88
Mar2022 ₹2,009 Cr
200.85
Mar2021 ₹668 Cr -

Compare Net Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹54,206.3 Cr -3% -5% 24.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,533.0 Cr 3.6% 2.5% 6.2% Stock Analytics
DIVIS LABORATORIES ₹180,215.0 Cr -2.9% 1.5% 48.1% Stock Analytics
CIPLA ₹120,428.0 Cr -0.1% -2.4% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹116,410.0 Cr 2.5% 4.9% 15.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,253.0 Cr -0.7% -6.4% -5.2% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-3%

-5%

24.5%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses